Terms: = Endocrine gland cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396
172 results:
1. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
[TBL] [Abstract] [Full Text] [Related]
2. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp.
Herman L; Amo A; Legois B; Di Carlo C; Veitia RA; Todeschini AL
Br J Cancer; 2024 May; 130(9):1453-1462. PubMed ID: 38429437
[TBL] [Abstract] [Full Text] [Related]
3. cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer.
Zhu Y; Fang S; Fan B; Xu K; Xu L; Wang L; Zhu L; Chen C; Wu R; Ni J; Wang J
Theranostics; 2024; 14(4):1683-1700. PubMed ID: 38389839
[No Abstract] [Full Text] [Related]
4. Paeonol impacts ovarian cancer cell proliferation, migration, invasion and apoptosis via modulating the transforming growth factor beta/smad3 signaling pathway.
Chen XM; Jia CL; Zhu ZY
J Physiol Pharmacol; 2023 Dec; 74(6):. PubMed ID: 38345445
[TBL] [Abstract] [Full Text] [Related]
5. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/smad pathway.
Wang Y; Zhang A; Li Q; Liu C
J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
[TBL] [Abstract] [Full Text] [Related]
6. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptomic Analysis of the Aged Nulliparous Mouse Ovary Suggests a Stress State That Promotes Pro-Inflammatory Lipid Signaling and Epithelial Cell Enrichment.
Chacón C; Mounieres C; Ampuero S; Urzúa U
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203684
[TBL] [Abstract] [Full Text] [Related]
8. Genetic predisposition to differentiated thyroid cancer in the Polish population.
Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
[TBL] [Abstract] [Full Text] [Related]
9. Metabolic characteristics of granulosa cell tumor: role of PPARγ signaling†.
Yu SY; Luan Y; Xu PC; Zhang Y; Dong R; Abazarikia A; Kim SY
Biol Reprod; 2024 Mar; 110(3):509-520. PubMed ID: 38123510
[TBL] [Abstract] [Full Text] [Related]
10. Somatostatin Inhibited the EMT of Pancreatic cancer Cells by Mediating the TGF-β/smad Signaling Pathway.
Zhou X; Wang W; Liu L
Discov Med; 2023 Dec; 35(179):1086-1092. PubMed ID: 38058074
[TBL] [Abstract] [Full Text] [Related]
11. An NFATc1/smad3/cJUN Complex Restricted to smad4-Deficient Pancreatic cancer Guides Rational Therapies.
Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
[TBL] [Abstract] [Full Text] [Related]
12. Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas.
Jin L; Cai K; Wu W; Xiao Y; Qiao N; Liu F; Ru S; Cao L; Zhu H; Bai J; Liu C; Li C; Zhao P; Zhang Y; Gui S
Front Endocrinol (Lausanne); 2023; 14():1167776. PubMed ID: 37854185
[TBL] [Abstract] [Full Text] [Related]
13. circEIF3I facilitates the recruitment of smad3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer.
Zhao Z; Yang W; Kong R; Zhang Y; Li L; Song Z; Chen H; Luo Y; Zhang T; Cheng C; Li G; Liu D; Geng X; Chen H; Wang Y; Pan S; Hu J; Sun B
Mol Cancer; 2023 Sep; 22(1):152. PubMed ID: 37689715
[TBL] [Abstract] [Full Text] [Related]
14. Proteomics Analysis Revealed smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian cancer.
Du R; Sun F; Li K; Qi J; Zhong W; Wang W; Sun Q; Deng Q; Wang H; Nie J; Ding C; Hong B
Anticancer Agents Med Chem; 2023; 23(15):1754-1764. PubMed ID: 37194931
[TBL] [Abstract] [Full Text] [Related]
15. Long-term (10-year) outcomes and prognostic factors in resected intraductal papillary mucinous neoplasm tumors in Finland: A nationwide retrospective study.
Vaalavuo Y; Vornanen M; Ahola R; Antila A; Rinta-Kiikka I; Sand J; Laukkarinen J
Surgery; 2023 Jul; 174(1):75-82. PubMed ID: 37062604
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract] [Full Text] [Related]
17. NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer.
Liu S; He X; Di Y; Li Q; Li F; Ma Y; Chen L; Gao Y; Xu J; Yang S; Xu L; Corpe C; Ling Y; Zhang X; Xu J; Yu W; Wang J
Carcinogenesis; 2023 May; 44(2):153-165. PubMed ID: 36591938
[TBL] [Abstract] [Full Text] [Related]
18. Loss of tumor suppressor WWOX accelerates pancreatic cancer development through promotion of TGFβ/BMP2 signaling.
Husanie H; Abu-Remaileh M; Maroun K; Abu-Tair L; Safadi H; Atlan K; Golan T; Aqeilan RI
Cell Death Dis; 2022 Dec; 13(12):1074. PubMed ID: 36572673
[TBL] [Abstract] [Full Text] [Related]
19. Tumour-derived exosomal piR-25783 promotes omental metastasis of ovarian carcinoma by inducing the fibroblast to myofibroblast transition.
Li G; Yi X; Du S; Gong L; Wu Q; Cai J; Sun S; Cao Y; Chen L; Xu L; Wang Z
Oncogene; 2023 Feb; 42(6):421-433. PubMed ID: 36482201
[TBL] [Abstract] [Full Text] [Related]
20. Identification of a novel cell cycle-related risk signature predicting prognosis in patients with pancreatic adenocarcinoma.
Xu D; Qin R; Li M; Shen J; Mao Y; Tang K; Zhang A; Wang D; Shi Y
Medicine (Baltimore); 2022 Nov; 101(46):e29683. PubMed ID: 36401386
[TBL] [Abstract] [Full Text] [Related]
[Next]
